Skip to content

Metal Versus Plastic Stent in Malignant Hilar Biliary Obstruction

Comparison of Metal Versus Plastic Side-by-side Stent Insertion in Malignant Hilar Biliary Obstruction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03857958
Enrollment
54
Registered
2019-02-28
Start date
2019-02-15
Completion date
2021-06-30
Last updated
2019-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Hepatobiliary Neoplasm

Brief summary

The purpose of this study was to compare the difference in the stent patency duration between side-by-side fully covered self-expanding metal stents (SEMS) and side-by-side plastic stents in patients with malignant hilar biliary obstruction.

Detailed description

In the case of distal common bile duct obstruction, the SEMS was reported to be clinically superior to the plastic stent in previous studies. However, there are few studies comparing the two methods in patients with malignant hilar biliary obstruction. In contrast to the distal common bile duct obstruction, the advantage of plastic stents over SEMSs exists, and plastic stents are used commonly in real clinical practice.

Interventions

PROCEDUREendoscopic retrograde cholangio-pancreatography

In patients who were identified to have malignant hilar biliary obstruction, bilateral stents insertion is attempted via ERCP. There will be two groups divided by stent material; FCSEMS and Plastic stent.

Sponsors

Taewoong Medical Co., Ltd.
CollaboratorINDUSTRY
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Unresectable malignant hilar biliary stricture requiring biliary drainage through endoscopic procedure

Exclusion criteria

* If endoscopy is not possible based on the judgement of the researcher * Life expectancy less than 6 months * Acute cholecystitis * Previous history of percutaneous transhepatic biliary drainage * Previous history of metal stent placement for malignant biliary stricture

Design outcomes

Primary

MeasureTime frameDescription
Duration of stent patency9 months after randomization.The period from the insertion of the stent to the point at which stent revision is required.

Countries

South Korea

Contacts

Primary ContactMin su You, MD
bass105@hanmail.net82-2-2072-2228
Backup ContactWoo Hyun Paik, MD, PhD
whpaik@snuh.org82-2-2072-2228

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026